These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Contrast-induced nephropathy: a clinical and evidence-based approach. Tepel M; Aspelin P; Lameire N Circulation; 2006 Apr; 113(14):1799-806. PubMed ID: 16606801 [No Abstract] [Full Text] [Related]
23. [Study of 2 methods to avoid the nephropathy associated with radiologic contrast]. Negri AL Medicina (B Aires); 1999; 59(6):776. PubMed ID: 10752227 [No Abstract] [Full Text] [Related]
24. Preventing nephropathy induced by contrast medium. Tepel M N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16642596 [No Abstract] [Full Text] [Related]
25. Sodium bicarbonate therapy and contrast-induced nephropathy. Singh D Am J Kidney Dis; 2009 Aug; 54(2):390; author reply 390-2. PubMed ID: 19619849 [No Abstract] [Full Text] [Related]
26. Re: Using estimated GFR values to identify patients at risk from iodinated contrast-induced nephropathy. Dyer JD; Dyer JB Clin Radiol; 2007 Mar; 62(3):285; author reply 285. PubMed ID: 17293225 [No Abstract] [Full Text] [Related]
27. [Progression prevention, diagnosis, and treatment of contrast agent-induced nephropathy]. Potekhin NP; Nikitin AV; Evsiukov KB; Klopotskiĭ SA; Zaĭtseva EA Voen Med Zh; 2009 Jun; 330(6):27-32. PubMed ID: 19791685 [No Abstract] [Full Text] [Related]
28. N-acetylcysteine and contrast-induced nephropathy. Wolak A; Cafri C; Zahger D N Engl J Med; 2006 Oct; 355(14):1498; author reply 1499-500. PubMed ID: 17024739 [No Abstract] [Full Text] [Related]
29. Using estimated GFR values to identify patients at risk from iodinated contrast induced nephropathy. Adair W; Harris K; Entwisle J Clin Radiol; 2006 Aug; 61(8):714-5. PubMed ID: 16843758 [No Abstract] [Full Text] [Related]
30. Radiocontrast nephropathy: a time for affirmative action. Rebeiz AG; Kandzari DE; Wang A; Sketch MH J Invasive Cardiol; 2003 Jan; 15(1):23-5. PubMed ID: 12499524 [No Abstract] [Full Text] [Related]
31. [The use of acetylcysteine for preventing contrast-induced nephropathy]. Schaad N; Barghouth G Rev Med Suisse; 2005 Jun; 1(25):1693-6. PubMed ID: 16117036 [No Abstract] [Full Text] [Related]
32. Contrast-induced nephropathy: prevention and management of high-risk patients. Caixeta A; Nikolsky E; Mehran R Indian Heart J; 2008; 60(6):524-31. PubMed ID: 19276490 [No Abstract] [Full Text] [Related]
33. [Review of the radiocontrast nephropathy risk profiles and risk stratification]. Toprak O; Cirit M; Bayata S; Yeşil M Anadolu Kardiyol Derg; 2004 Dec; 4(4):331-5. PubMed ID: 15590363 [TBL] [Abstract][Full Text] [Related]
34. Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiography. Marenzi G Nat Clin Pract Nephrol; 2008 Mar; 4(3):130-1. PubMed ID: 18059387 [No Abstract] [Full Text] [Related]
35. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed]. Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735 [No Abstract] [Full Text] [Related]
36. Contrast-induced nephropathy remains a serious complication of PCI. Mehran R J Interv Cardiol; 2007 Jun; 20(3):236-40. PubMed ID: 17524117 [No Abstract] [Full Text] [Related]